Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Cardiology

PAD: The other arterial disease

The body has two types of artery systems: the coronary artery system, which relates to the heart, and peripheral artery system, which involves the arteries carrying oxygenated blood to the arms, legs and brain.

Medications

Blood thinners and COVID: The findings guiding patient care

When SARS-CoV-2, the virus that causes COVID-19, first emerged in late 2019, researchers quickly assembled to understand its effects and figure out how to stop its spread. Soon, late-night phone calls and global collaborations ...

page 3 from 25